Opportunities Preloader

Please Wait.....

Report

Xerostomia (Dry Mouth Disease) Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Market Report I 2023-10-15 I 147 Pages I IMARC Group

Market Overview:

The global xerostomia (dry mouth disease) therapeutics market size reached US$ 714 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 893 Million by 2028, exhibiting a growth rate (CAGR) of 3.6% during 2023-2028.

Xerostomia, or dry mouth, refers to symptoms or sensations of oral dryness that are usually caused due to a decrease in the amount of saliva. This condition is triggered by the adverse effects of radioactivity in the neck and head, increasing consumption of antianxiety drugs, dehydration, diabetes, and Alzheimer's disorder. It can be treated with the support of salivary pens or stimulants, artificial saliva, prescribed medications, and home remedies, including sipping water and moisturizing lips. Apart from this, the early diagnosis of salivary glands by practitioners and the usage of recommended mouth moisturizing products, such as over-the-counter (OTC) rinsing, can assist in lubricating the mouth. These treatments alleviate discomfort, prevent severe complications, fix taste disorders, and mitigate bad breath and taste disorders. Consequently, xerostomia therapeutics are used across several hospitals and clinics to deal with decreased salivary gland function.

Xerostomia (Dry Mouth Disease) Therapeutics Market Trends:
The increasing incidences of dry mouth, especially amongst the geriatric population, due to medicine side-effects of radiotherapy and chemotherapy and the rising need for dry mouth relief products are primarily driving the market growth. Additionally, the growing uptake of several prescription-based toothpaste, vitamin gummies, and medicines for treating Sjogren's syndrome, Alzheimer's diseases, and human immunodeficiency virus (HIV) that cause xerostomia is acting as another growth-inducing factor. In line with this, the rising consumer awareness regarding the early diagnosis of xerostomia, significant enhancements in healthcare expenditure, and the advent of diverse diagnostic technologies are propelling the market growth. Moreover, the favorable initiatives being commenced by governments to sensitize consumers regarding the xerostomia disease, its symptoms, causes, and treatments are impelling the market growth. Apart from this, the easy availability of various therapeutic drugs and ongoing research and development (R&D) activities are creating a positive outlook for the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global xerostomia (dry mouth disease) therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, drug type and distribution channel.

Breakup by Type:

Artificial Saliva/Saliva Substitutes
Salivary Stimulants

Breakup by Drug Type:

OTC
Prescription

Breakup by Distribution Channel:

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Biotene (GSK plc), Parnell Pharmaceuticals Inc., Quest Products LLC, Saliwell Ltd, Sun Pharmaceutical Industries Limited and West-Ward Pharmaceutical (Hikma Pharmaceuticals plc).

Key Questions Answered in This Report

1. How big is the global xerostomia (dry mouth disease) therapeutics market?
2. What is the expected growth rate of the global xerostomia (dry mouth disease) therapeutics market during 2023-2028?
3. What are the key factors driving the global xerostomia (dry mouth disease) therapeutics market?
4. What has been the impact of COVID-19 on the global xerostomia (dry mouth disease) therapeutics market?
5. What is the breakup of the global xerostomia (dry mouth disease) therapeutics market based on type?
6. What is the breakup of the global xerostomia (dry mouth disease) therapeutics market based on the drug type?
7. What is the breakup of the global xerostomia (dry mouth disease) therapeutics market based on the distribution channel?
8. What are the key regions in the global xerostomia (dry mouth disease) therapeutics market?
9. Who are the key players/companies in the global xerostomia (dry mouth disease) therapeutics market?

1Preface
2Scope and Methodology
2.1Objectives of the Study
2.2Stakeholders
2.3Data Sources
2.3.1Primary Sources
2.3.2Secondary Sources
2.4Market Estimation
2.4.1Bottom-Up Approach
2.4.2Top-Down Approach
2.5Forecasting Methodology
3Executive Summary
4Introduction
4.1Overview
4.2Key Industry Trends
5Global Xerostomia (Dry Mouth Disease) Therapeutics Market
5.1Market Overview
5.2Market Performance
5.3Impact of COVID-19
5.4Market Forecast
6Market Breakup by Type
6.1Artificial Saliva/Saliva Substitutes
6.1.1 Market Trends
6.1.2 Market Forecast
6.2Salivary Stimulants
6.2.1 Market Trends
6.2.2 Market Forecast
7Market Breakup by Drug Type
7.1OTC
7.1.1 Market Trends
7.1.2 Market Forecast
7.2Prescription
7.2.1 Market Trends
7.2.2 Market Forecast
8Market Breakup by Distribution Channel
8.1Hospital Pharmacy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2Retail Pharmacy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3Online Pharmacy
8.3.1 Market Trends
8.3.2 Market Forecast
9Market Breakup by Region
9.1North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10SWOT Analysis
10.1Overview
10.2Strengths
10.3Weaknesses
10.4Opportunities
10.5Threats
11Value Chain Analysis
12Porters Five Forces Analysis
12.1Overview
12.2Bargaining Power of Buyers
12.3Bargaining Power of Suppliers
12.4Degree of Competition
12.5Threat of New Entrants
12.6Threat of Substitutes
13Price Analysis
14Competitive Landscape
14.1Market Structure
14.2Key Players
14.3Profiles of Key Players
14.3.13M Company
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2Biotene (GSK plc)
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3Parnell Pharmaceuticals Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4Quest Products LLC
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5Saliwell Ltd
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6Sun Pharmaceutical Industries Limited
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7West-Ward Pharmaceutical (Hikma Pharmaceuticals plc)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio

Figure 1: Global: Xerostomia Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Xerostomia Therapeutics Market: Breakup by Type (in %), 2022
Figure 5: Global: Xerostomia Therapeutics Market: Breakup by Drug Type (in %), 2022
Figure 6: Global: Xerostomia Therapeutics Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: Xerostomia Therapeutics Market: Breakup by Region (in %), 2022
Figure 8: Global: Xerostomia Therapeutics (Artificial Saliva/Saliva Substitutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Xerostomia Therapeutics (Artificial Saliva/Saliva Substitutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Xerostomia Therapeutics (Salivary Stimulants) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Xerostomia Therapeutics (Salivary Stimulants) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Xerostomia Therapeutics (OTC) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Xerostomia Therapeutics (OTC) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Xerostomia Therapeutics (Prescription) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Xerostomia Therapeutics (Prescription) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Xerostomia Therapeutics (Hospital Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Xerostomia Therapeutics (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Xerostomia Therapeutics (Retail Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Xerostomia Therapeutics (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Xerostomia Therapeutics (Online Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Xerostomia Therapeutics (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: North America: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: North America: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: United States: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: United States: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Canada: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Canada: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Asia-Pacific: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Asia-Pacific: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: China: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: China: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Japan: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Japan: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: India: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: India: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: South Korea: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: South Korea: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Australia: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Australia: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Indonesia: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Indonesia: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Others: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Others: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Europe: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Europe: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Germany: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Germany: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: France: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: France: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: United Kingdom: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: United Kingdom: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Italy: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Italy: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Spain: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Spain: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Russia: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Russia: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Others: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Others: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Latin America: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Latin America: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Brazil: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Brazil: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Mexico: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Mexico: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Others: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Others: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Middle East and Africa: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Middle East and Africa: Xerostomia Therapeutics Market: Breakup by Country (in %), 2022
Figure 70: Middle East and Africa: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Global: Xerostomia Therapeutics Industry: SWOT Analysis
Figure 72: Global: Xerostomia Therapeutics Industry: Value Chain Analysis
Figure 73: Global: Xerostomia Therapeutics Industry: Porter's Five Forces Analysis

Table 1: Global: Xerostomia Therapeutics Market: Key Industry Highlights 2022 and 2028
Table 2: Global: Xerostomia Therapeutics Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Xerostomia Therapeutics Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
Table 4: Global: Xerostomia Therapeutics Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 5: Global: Xerostomia Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Xerostomia Therapeutics Market: Competitive Structure
Table 7: Global: Xerostomia Therapeutics Market: Key Players

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $2499.00
  • $3499.00
  • $4499.00
  • ADD TO BASKET
  • BUY NOW